525 related articles for article (PubMed ID: 28811267)
1. APP/Aβ structural diversity and Alzheimer's disease pathogenesis.
Roher AE; Kokjohn TA; Clarke SG; Sierks MR; Maarouf CL; Serrano GE; Sabbagh MS; Beach TG
Neurochem Int; 2017 Nov; 110():1-13. PubMed ID: 28811267
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys J; Valverde A; Checler F
J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
[TBL] [Abstract][Full Text] [Related]
4. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
Klementieva O; Willén K; Martinsson I; Israelsson B; Engdahl A; Cladera J; Uvdal P; Gouras GK
Nat Commun; 2017 Mar; 8():14726. PubMed ID: 28287086
[TBL] [Abstract][Full Text] [Related]
5. The role of amyloid in the pathogenesis of Alzheimer's disease.
Verbeek MM; Ruiter DJ; de Waal RM
Biol Chem; 1997 Sep; 378(9):937-50. PubMed ID: 9348103
[TBL] [Abstract][Full Text] [Related]
6. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
7. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
Lecordier S; Pons V; Rivest S; ElAli A
Front Immunol; 2021; 12():813536. PubMed ID: 35173711
[TBL] [Abstract][Full Text] [Related]
8. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
[TBL] [Abstract][Full Text] [Related]
9. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
10. Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.
Cabrera E; Mathews P; Mezhericher E; Beach TG; Deng J; Neubert TA; Rostagno A; Ghiso J
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):208-225. PubMed ID: 28711595
[TBL] [Abstract][Full Text] [Related]
11. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
[TBL] [Abstract][Full Text] [Related]
12. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
14. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
15. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.
Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM
J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325
[TBL] [Abstract][Full Text] [Related]
16. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
17. Modeling the Competition between Misfolded Aβ Conformers That Produce Distinct Types of Amyloid Pathology in Alzheimer's Disease.
Xu G; Fromholt S; Borchelt DR
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883442
[TBL] [Abstract][Full Text] [Related]
18. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
[TBL] [Abstract][Full Text] [Related]
19. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
[TBL] [Abstract][Full Text] [Related]
20. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
